New bladder pain cocktail tested – but study halted early

NCT ID NCT02591199

Terminated Symptom relief Sponsor: Urigen Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a single dose of URG101, a combination of lidocaine and heparin, to see if it safely reduces bladder pain in people with Interstitial Cystitis/Bladder Pain Syndrome. The trial was randomized and double-blind, meaning neither patients nor doctors knew who got the real drug or placebo. The study was terminated early, so results are limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER PAIN SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

interstitial cystitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLADDER PAIN SYNDROME INTERSTITIAL CYSTITIS

Contacts and locations

Locations

Georgia Urology

Cartersville, Georgia, 30120, United States
IC Study, LLC

Escondido, California, 92025, United States
Medical University of South Carolina

Charleston, South Carolina, 29425, United States
MetroHealth System, Center for Advanced Gynecology

Cleveland, Ohio, 44109, United States
Rutgers Women's Health Clinic

New Brunswick, New Jersey, 08901, United States
Sanford Research

Sioux Falls, South Dakota, 57105, United States
The Arthur Smith Institue for Urology- North Shore Long Island Jewish Health System

Lake Success, New York, 11042, United States
The Urogynecology Center

Overland Park, Kansas, 66209, United States
University of California San Diego

San Diego, California, 92103, United States
Urology of Virginia, PLLC

Virginia Beach, Virginia, 23462, United States
Wake Forest University Health Sciences

Winston-Salem, North Carolina, 27103, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.